Potassium cyclohexenyltrifluoroborate

Product Information

Molecular Formula:
C6H9BF3K
Molecular Weight:
188.04
Description
Potassium benzothiophene-3-trifluoroborate is a vital component in the biomedical industry, utilized for the development of pharmaceutical drugs targeting various diseases. This compound plays a crucial role in the synthesis of novel therapeutic agents designed to treat conditions like cancer, inflammation, and infectious diseases.
Synonyms
Potassium 1-cyclohexen-1-yltrifluoroborate
IUPAC Name
potassiumcyclohexen-1-yl(trifluoro)boranuide
Canonical SMILES
[B-](C1=CCCCC1)(F)(F)F.[K+]
InChI
InChI=1S/C6H9BF3.K/c8-7(9,10)6-4-2-1-3-5-6/h4H,1-3,5H2/q-1+1
InChI Key
HGMUFAMKMWVCQO-UHFFFAOYSA-N
Melting Point
191-196 °C
Flash Point
Not applicable

Safety Information

Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338

Computed Properties

Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
0
Exact Mass
188.0386464 g/mol
Monoisotopic Mass
188.0386464 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
11
Formal Charge
0
Complexity
152
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
CA-3085967-A1 4-(1h-imidazol-5-yl)-1h-pyrrolo[2,3-b]pyridines for use in the treatment of leukaemias, lymphomas and solid tumors 2018-03-29
KR-20200116137-A 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine for use in the treatment of leukemia, lymphoma and solid tumors 2018-03-29
US-2021040086-A1 4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors 2018-03-29
EP-3774795-B1 4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors 2018-03-29
EP-2675811-A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation 2011-02-17
JP-2014506887-A Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation 2011-02-17
US-2013053404-A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation 2011-02-17
WO-2012110599-A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation 2011-02-17
AU-2011217206-A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation 2010-02-19
CA-2790643-A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation 2010-02-19
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Inquiry Basket